HIGHLIGHTS
- who: Aleksandr Kalininskiy from the Using an existing ILD registry database at the University of Rochester (n=498), we identified , patients with a diagnosis of IPF (based on URMC MDD consensus diagnosis as outlined in the ATS/ERS/EJRS/ALAT clinical practice guideline [25])Written consent was obtained from all subjects. Data collection was started in, . , patients had at least , year of longitudinal pulmonary function test data and weight measurements. Data from , patients were collected prior to , when pirfenidone and nintedanib were FDA approved for the treatment of IPF and these patients were therefore not taking an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.